Those looking into the premarket action this morning might do well to take a look at the Applied Genetic Technologies Inc (NASDAQ:AGTC), which has jumped by as much as 14% so far. The rally in the stock is possibly in anticipation of the fact that the company is going to present the 12 month data from the Phase 1/2 of Achromatopsia trials later on today.
Hence, it is not really a surprise that the stock is in sharp focus and it is not going to be a surprise if the stock continues to be in focus over the rest of the day.
The results that are going to be published today are going to be related to the data from treating adults and paediatric patients who might have needed a low dose. The Applied Genetics Technologies Inc management is going to host a conference call today at 8 a.m. Eastern Time.
The conference is also going to be available on a webcast and investors who are interested could consider going to the company’s website in order to access it. In addition to that data from this particular phase, the company is also going to provide details with regards to the next phase of trials.
As of 7:14, AGTC stock is trading higher by 11% to $4.62 on moderate volume in the pre-market session.
 Stock Gains Ahead of Key Presentation: What Next?){kind=link}